Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03213041 | Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer | completed | Phase 2 | 12 | Northwestern UniversityOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT01730833 | Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer | completed | Phase 2 | 63 | City of Hope Medical CenterOTHER | 1 | Jun 16, 2026 |
| NCT07651020 | The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors | completed | — | 1 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT04737265 | Pilot Study of an NTproBNP Guided Strategy of Cardioprotection(NTproBNP-Guide) | completed | Phase 1 / Phase 2 | 108 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT05030038 | Oral Aromatase Inhibitors Modify the Gut Microbiome | completed | — | 24 | Wake Forest University Health SciencesOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT07108959 | ESPB Versus Perioperative Iv Lidocaine Infusion on Proinflammatory Cytokines in Breast Cancer Surgeries(ESPB) | completed | N/A | 40 | Alexandria UniversityOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT07647042 | A Real-World Study of Early Breast Cancer Patients Eligible for Treatment With CDK4/6 Inhibitors(LEEWARD) | completed | — | 750 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 15, 2026 | clinicaltrials |
| NCT07648940 | Bioequivalence Study of Liposomal Doxorubicin 20 mg/10 mL (Doxopeg® vs Caelyx®) in Advanced Cancer Patients | completed | Phase 1 | 74 | Zodiac Produtos Farmaceuticos S.A.INDUSTRY | 1 | Jun 15, 2026 | clinicaltrials |
| NCT01556243 | Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer | completed | Phase 2 | 270 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT03107234 | Involvement of the Inositol-trisphosphate Receptor in Invasive or Migratory-type Breast Cancers(CarcIno) | completed | — | 42 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT05301998 | Tridimensional Geometric Modeling of the Breast(SENO 3D) | completed | N/A | 200 | University Hospital, MontpellierOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT07644858 | MammoVerse: Breast Cancer Sexual Health Focus Groups | completed | — | 24 | University of Central FloridaOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT05303129 | Prognostic Impact of the Neutrophil/Lymphocyte Ratio (NLR) in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK4/6 Inhibitor.(PEPSI) | completed | N/A | 165 | Centre Francois BaclesseOTHER | 1 | Jun 11, 2026 | clinicaltrials |
| NCT06035731 | Evaluation of the Medical Service by Socio-aesthetics in Oncology(RCT-SE) | completed | N/A | 400 | Centre Hospitalier de ValenceOTHER | 1 | Jun 11, 2026 | clinicaltrials |
| NCT07641114 | Behavior Change Wheel-Based Music Listening for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients(BCW-MUSIC) | completed | N/A | 90 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jun 11, 2026 | clinicaltrials |
| NCT02392845 | A Pilot Dose Escalation Trial of a Densified Chemotherapy Association of Docetaxel and Epirubicin Driven by Mathematical Modeling in Metastatic Breast Cancer Patients: The MODEL1 Study(MODEL1) | completed | Phase 1 | 17 | Hospices Civils de LyonOTHER | 1 | Jun 10, 2026 | clinicaltrials |
| NCT04937660 | Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC(PRECIOUS) | completed | — | 185 | PfizerINDUSTRY | 5 | Jun 10, 2026 | clinicaltrials |
| NCT05666258 | Gene Expression Profiling to Help Define the Need for Neo-Adjuvant Chemotherapy in HR+, HER- Breast Cancer Patients(NACAGEP) | completed | — | 22 | Universitair Ziekenhuis BrusselOTHER | 1 | Jun 10, 2026 | clinicaltrials |
| NCT06219187 | Male breAsT cAncer preDisposition Factor(MATADOR) | completed | — | 93 | Institut Claudius RegaudOTHER | 1 | Jun 10, 2026 | clinicaltrials |
| NCT06253195 | BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors | completed | Phase 1 | 33 | BeOne MedicinesINDUSTRY | 1 | Jun 10, 2026 | clinicaltrials |
| NCT03051828 | Physical Evaluation and Quality of Life in the Practice of Fencing in Breast Cancer Support(ESCRIME) | completed | — | 30 | Hôpital NOVOOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT06513364 | Neoadjuvant Chemotherapy With WH002 in Women With HER2-negative Breast Cancer | completed | Phase 2 | 40 | Beijing Wehand-Bio Pharmaceutical Co., LtdINDUSTRY | 1 | Jun 9, 2026 | clinicaltrials |
| NCT03289962 | A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors | completed | Phase 1 | 273 | Genentech, Inc.INDUSTRY | 8 | Jun 8, 2026 | clinicaltrials |
| NCT05856656 | Music Therapy as a Tool for Anxiety Reduction in Localized Breast Cancer(CENSORIAL) | completed | N/A | 27 | Institut Cancerologie de l'OuestOTHER | 1 | Jun 8, 2026 | clinicaltrials |
| NCT07320521 | A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects. | completed | Phase 1 | 6 | Shandong Suncadia Medicine Co., Ltd.INDUSTRY | 1 | Jun 8, 2026 | clinicaltrials |
| NCT07631962 | Impact of Radiotherapy on Survival in Breast Cancer Patients | completed | — | 1,030 | Motamed Cancer InstituteOTHER | 0 | Jun 8, 2026 | clinicaltrials |
| NCT06570031 | ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer | completed | Phase 1 | 46 | Ono Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 5, 2026 | clinicaltrials |
| NCT03975959 | Memory Perception Assessment in Central/Non-central Nervous System Cancers(PROMESSE) | completed | N/A | 426 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT06455657 | Breast Cancer Education to Prisoner Women | completed | N/A | 40 | Hitit UniversityOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT06710990 | Investigation of Drug-drug Interaction of Ritonavir and Itraconazole on the Pharmacokinetics of SHR-A1811 in Subjects With HER2-expressing Advanced Breast Cancer | completed | Phase 1 | 17 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jun 4, 2026 | clinicaltrials |
| NCT05623397 | A Deep Learning Method to Evaluate QT on Ribociclib(QT-RIBRATING) | completed | — | 70 | CMC Ambroise ParéOTHER | 1 | Jun 3, 2026 | clinicaltrials |
| NCT04418856 | The Effects of Light Therapy to Treat Cancer-related Side Effects | completed | N/A | 260 | Reykjavik UniversityOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT05038137 | Time Restricted Eating on Cancer Risk(TREC) | completed | N/A | 29 | Medical University of South CarolinaOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT05505175 | Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBC | completed | — | 121 | PfizerINDUSTRY | 1 | Jun 2, 2026 | clinicaltrials |
| NCT06767059 | The Effect of Walking and Grounding in Women With Breast Cancer | completed | N/A | 55 | Ankara UniversityOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT06106165 | Improving Muslim Women's Uptake of Cancer Screening (IMCAN)(IMCAN) | completed | N/A | 169 | University of SunderlandOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT06940310 | Different Resistance Training Intensity Prescription and Monitoring Methodologies: Effects on Strength, Body Composition, and Well-being in Survivors of Breast Cancer | completed | N/A | 61 | Universidad de AlmeriaOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT03712813 | Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors | completed | N/A | 72 | Indiana UniversityOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT06300411 | SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery | completed | Phase 1 | 25 | SURGE TherapeuticsINDUSTRY | 1 | May 28, 2026 | clinicaltrials |
| NCT07148336 | Identification of Chemotherapy-induced Peripheral Neuropathy(NEURO-BREAC) | completed | N/A | 26 | University Hospital Schleswig-HolsteinOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT00600496 | A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) | completed | Phase 1 | 140 | AstraZenecaINDUSTRY | 1 | May 27, 2026 | clinicaltrials |
| NCT04107636 | Minimal Invasive Breast Cancer Excision Using Vacuum Assisted Biopsy Under Ultrasound Guidance(MINIVAB) | completed | N/A | 45 | Radboud University Medical CenterOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT05181462 | Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.(TRIFOUR) | completed | Phase 1 / Phase 2 | 117 | Cantargia ABINDUSTRY | 1 | May 27, 2026 | clinicaltrials |
| NCT05955833 | 89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study(HER Image) | completed | N/A | 6 | Amsterdam UMC, location VUmcOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT06461663 | CairnSurgical Breast Cancer Locator (BCL) Post-Market Study | completed | N/A | 35 | CairnSurgical, Inc.INDUSTRY | 3 | May 27, 2026 | clinicaltrials |
| NCT06619873 | A Clinical Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Healthy Subjects | completed | Phase 1 | 24 | Shandong Suncadia Medicine Co., Ltd.INDUSTRY | 1 | May 27, 2026 | clinicaltrials |
| NCT04296162 | Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID)(ORCHID) | completed | Phase 2 | 182 | Fudan UniversityOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT07607548 | Assessment of the Effect of Probiotic Supplementation on Proinflammatory Mechanisms Induced by Systemic Treatment in Women With Breast Cancer | completed | N/A | 60 | Poznan University of Medical SciencesOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT03789097 | Vaccination With Flt3L, Radiation, and Poly-ICLC | completed | Phase 1 / Phase 2 | 17 | Icahn School of Medicine at Mount SinaiOTHER | 1 | May 22, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Jun 17, 2026source: clinicaltrials